USPTO 2015–2025 USPTO PatentsView US Corporation

Tesseract Health, Inc.

USPTO PatentsView assignee record - 9 granted patents across 11 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

RSS updates for this company

The verdict

According to USPTO PatentsView, Tesseract ranks #30,366 of 49,997 tracked US assignees by granted-patent volume, with 9 patents across 11 technology areas.

#30,366
of 49,997 US assignees by volume
Top 18%
by Innovation Score (47.9/100)
13.7
avg claims per patent
+600%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R30366 · US Corporation #30,366 · 9 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-MICRO 9 grants
  • MID-PACK #30,366/49,997
  • PHOTO-FINISH Tenaris Connections
  • CPC-FOCUS A61B · 11 areas
  • INNOV-PAR 47.9/100
  • CLAIMS-RICH 13.7 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-SURGE +600% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Tenaris Connections Limited (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Tesseract

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Tesseract's Innovation Score is 47.9/100 (top 18% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Tesseract's grants concentrate

Tesseract Health, Inc. is a focused PatentsView assignee: 11 CPC subclasses with 55.6% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2022 (6 grants) versus a trough of 1 in 2019. By volume, Tesseract sits between Tenaris Connections Limited and Texas LFP, LLC.

Tesseract's three-year grant acceleration

Tesseract Health, Inc. shows 7 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Tesseract's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Tesseract holds 9 patents at rank #30,384, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Tesseract

By rank, the assignees closest to #30,384 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Tesseract's primary technology class.

Tesseract's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

48 Top 18% higher than 82% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

02468 2019202220232025 1
USPTO utility patent grants by year · 2019–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table
Tesseract Health, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2019 1 11.1%
2022 6 66.7%
2023 1 11.1%
2025partial year 1 11.1%

Where it ranks

Overall rank by patents

#30,366

of 49,997 tracked assignees

Innovation Score

47.9 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Tesseract Health, Inc.'s patent record in context - here's where to go next.

  • Tesseract Health, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 55.6% of its portfolio - see every assignee active in that class. Explore A61B
  • Ranked #30,366 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Tesseract Health, Inc. against Tenaris Connections Limited, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 47.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.